CURRICULUM VITAE

NAME:

David J. P. FitzGerald

EDUCATION:

    1977 B.A.  -- Trinity College, University of Dublin, Ireland;
		  Moderatorship in Microbiology, Second class 
		  honors, first division.

    1982 Ph.D. -- University of Cincinnati, College of Medicine,
		  Department of Microbiology.

BRIEF CHRONOLOGY OF EMPLOYMENT:

    1982-1984    -- Staff Fellow, Laboratory of Molecular Biology,
		    National Cancer Institute, National Institutes 
		    of Health

    1985-1987    -- Senior Staff Fellow, Laboratory of Molecular
		    Biology, National Cancer Institute, NIH

    1987-1994    -- Microbiologist, (Senior Investigator)
		    Laboratory of Molecular Biology, National
		    Cancer Institute, NIH

    1994-present -- Chief, Biotherapy Section, Laboratory of Molecular 
		    Biology, National Cancer Institute, NIH

EDITORIAL BOARDS

Infection and Immunity (1987-1989)

Journal of National Cancer Institute (1990-1994)

Journal of Pharmaceutical Sciences

Journal of Bioconjugate Chemistry (1990-1994)

Journal of Drug Targeting

Therapeutic Immunity

Journal of Biological Chemistry (1996-present)

SOCIETIES

AAAS

American Society for Biochemistry and Molecular Biology

American Association for Cancer Research

HONORS:

Albert J. Ryan Fellowship (January 1980)

NIH Director's Award (June 1991)

Pierce Immunotoxin Award (June 1992)

NIH Award of Merit (September 1995)

OTHER SPECIAL SCIENTIFIC RECOGNITION:

Chairman of Gordon Conference (1994) Assisted with planning of DAHLEM Conference (Nov. 1989), Berlin

PATENTS:

    Pastan, I., Willingham, M.C., and FitzGerald, D.J.:  Pseudomonas 
	exotoxin conjugate immunotoxins.  (Assignee:  U.S.A., D.H.H.S.)
	(Filed January 26, 1984.)  Granted U.S. Patent #4,545,985, 
	October 8, 1985.

    Pastan, I., FitzGerald, D.J.P., and Willingham, M.C.: Monoclonal 
	antibody against ovarian cancer cells (OVB3).  Patent 
	#4,806,494, February 21, 1989.

    Pastan, I., Adhya, S., and FitzGerald, D.J.P.:  Recombinant 
	Pseudomonas Exotoxin,:  Construction of an active immunotoxin 
	with low side effects.  Patent # 4,892,827, January 9, 1990.

Return to David FitzGerald Information Page or

return to Laboratory of Molecular Biology Home Page